Advancing Schizophrenia Care: Challenges and Promising New Therapies
Charles Turck, PharmD, BCPS, BCCCP
Andrew J. Cutler, MD
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Clifford Jack Jr., MD
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Ashley Baker, MSN, PMHNP
Suzanne E. Schindler, MD, PhD
Diagnosing Myasthenia Gravis: The Impact of Social Media
Vishnu Pandurangadu, MD/MBA, FACEP
Pritikanta Paul, MD
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
John A. Morren, MD, FAAN, FAANEM
Bridging the Gap to Improved Schizophrenia Treatment Options
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
Brian P. McDonough, MD, FAAFP
John R. Corboy, MD
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
John Brandsema, MD
Continuum of Care: Managing DMD in Pediatric and Adult Patients
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
Jasmohan Bajaj, MD
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
Dr. Robert J. Shmookler Reis, PhD
Dr. Srinivas Ayyadevara, PhD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.